IQI
STRO icon

Integrated Quantitative Investments’s Sutro Biopharma STRO Stock Holding History

Integrated Quantitative Investments’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Buy
+8,939
New +$279K 0.05% 331

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Integrated Quantitative Investments's STRO Position: Q2 2026 in Review

Integrated Quantitative Investments opened a new position in Sutro Biopharma (STRO) in Q2 2026: 8,939 shares worth $297K. The stake represents 0.05% of the portfolio and ranks #331 among its holdings.

100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Integrated Quantitative Investments held 8,939 shares of Sutro Biopharma worth $297K as of Q2 2026.
  • Sutro Biopharma was a new Integrated Quantitative Investments position in Q2 2026.
  • Sutro Biopharma made up 0.05% of Integrated Quantitative Investments's portfolio in Q2 2026, its #331 holding.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.